Showing results (1591-1600 of 2,063) with videos related to
Sort By:
Pageof 207
Brachytherapy|January 24, 2022
Comparison of novel shielded nasopharynx applicator designs for intracavitary brachytherapyBenjamin Insley, Ken Goldberg, Luc Beaulieu, et al.Brachytherapy|October 17, 2021
125I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancerTimothy D Smile, Martin C Tom, Ahmed Halima, et al.Brachytherapy|April 15, 2022
Ureter dose optimization during image guided brachytherapy for cervical cancerAsma Sarwar, Narinder Lalli, Gemma EminowiczBrachytherapy|April 16, 2022
Retrospective review of three-fractioned accelerated partial breast irradiationLaura Elizabeth Simon, Daniel Scanderbeg, John Einck, et al.Brachytherapy|May 16, 2018
A novel applicator design for intracavitary brachytherapy of the nasopharynx: Simulated reconstruction, image-guided adaptive brachytherapy planning, and dosimetryWarren R Bacorro, Ryan Anthony F Agas, Stellar Marie R Cabrera, et al.Brachytherapy|November 28, 2023
Heterogeneous physical phantom for I-125 dose measurements and dose-to-medium determinationPaula Cristina Guimarães Antunes, Paulo de Tarso Dalledone Siqueira, Julian Marco Barbosa Shorto, et al.Brachytherapy|September 16, 2023
Improved safety and quality in intravascular brachytherapy: A multi-institutional study using failure modes and effects analysisEvan D H Gates, Kent Wallner, Jasleen Tiwana, et al.Brachytherapy|August 13, 2023
Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosisLong-Wang Lin, Le-Ye Yan, Kun Ke, et al.Brachytherapy|October 11, 2023
Redefining bladder neck dose in low-dose-rate prostate brachytherapy-Can we improve urinary toxicity without impacting disease control?Sean A Koerner, Ronald M Benoit, Sushil Beriwal, et al.Brachytherapy|October 8, 2023
US-guided EM tracked system for HDR brachytherapy: A first in-men randomized study for whole prostate treatmentMarie-Claude Lavallee, Audrey Cantin, Sylviane Aubin, et al.Pageof 207